A randomized phase II trial of adjuvant chemotherapy with gemcitabine versus S-1 after major hepatectomy for biliary tract cancer: Kansai Hepato-Biliary Oncology Group (KHBO1208)

被引：0
|
作者：
Terajima, H. [1 ]
Kobayashi, S. [2 ]
Nagano, H. [3 ]
Tomokuni, A. [4 ]
Gotoh, K. [2 ]
Sakai, D. [5 ]
Hatano, E. [6 ]
Seo, S. [7 ]
Uchida, Y. [1 ]
Ajiki, T. [8 ]
Satake, H. [9 ]
Kamei, K. [10 ]
Tohyama, T. [11 ]
Hirose, T. [12 ]
Ikai, I. [13 ]
Morita, S. [14 ]
Ioka, T. [15 ]
机构：
[1] Kitano Hosp, Tazuke Kofu Kai Med Res Inst, Dept Gastroenterol Surg & Oncol, Osaka, Japan
[2] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka, Japan
[3] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol Breast & Endocrine Surg, Yamaguchi, Japan
[4] Osaka Int Canc Inst, Dept Surg, Osaka, Japan
[5] Osaka Univ, Dept Frontier Sci Canc & Chemotherapy, Grad Sch Med, Suita, Osaka, Japan
[6] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo, Japan
[7] Kyoto Univ, Dept Surg, Grad Sch Med, Kyoto, Japan
[8] Kobe Univ, Grad Sch Med, Div Hepatobiliary Pancreat Surg, Dept Surg, Kobe, Hyogo, Japan
[9] Gen Hosp, Kobe City Med Ctr, Dept Med Oncol, Kobe, Hyogo, Japan
[10] Kindai Univ, Fac Med, Dept Surg, Osakasayama, Japan
[11] Ehime Univ, Dept Hepatobiliary Pancreat & Breast Surg, Grad Sch Med, Touon, Japan
[12] Otsu Red Cross Hosp, Dept Surg, Otsu, Shiga, Japan
[13] Natl Hosp Org Kyoto Med Ctr, Dept Surg, Kyoto, Japan
[14] Kyoto Univ, Dept Biomed Stat & Bioinformat, Grad Sch Med, Kyoto, Japan
[15] Osaka Int Canc Inst, Dept Canc Survey & Gatrointestinal Oncol, Osaka, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
762P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Prospective, Randomized Phase II Study of Adjuvant Gemcitabine Versus S-1 After Major Hepatectomy for Biliary Tract Cancer (KHBO 1208) Kansai Hepato-Biliary Oncology Group
    Kobayashi, Shogo
    Nagano, Hiroaki
    Tomokuni, Akira
    Gotoh, Kunihito
    Sakai, Daisuke
    Hatano, Etsuro
    Seo, Satoru
    Terajima, Hiroaki
    Uchida, Yoichiro
    Ajiki, Tetsuo
    Satake, Hironaga
    Kamei, Keiko
    Tohyama, Taiji
    Hirose, Tetsuro
    Ikai, Iwao
    Morita, Satoshi
    Ioka, Tatsuya
    ANNALS OF SURGERY, 2019, 270 (02) : 230 - 237
  • [2] The impact of peritoneal lavage cytology in biliary tract cancer (KHBO1701): Kansai Hepato-Biliary Oncology Group
    Matsukuma, Satoshi
    Nagano, Hiroaki
    Kobayashi, Shogo
    Wada, Hiroshi
    Seo, Satoru
    Tsugawa, Daisuke
    Okuyama, Hiroyuki
    Iida, Kenjiro
    Ohmura, Yoshiaki
    Takeda, Yutaka
    Miyamoto, Atsushi
    Nakashima, Shinsuke
    Yamada, Terumasa
    Ajiki, Tetsuo
    Tsuji, Akihito
    Yoshimura, Kenichi
    Eguchi, Hidetoshi
    Hatano, Etsuro
    Ioka, Tatsuya
    CANCER REPORTS, 2021, 4 (02)
  • [3] A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1202)
    Yanagimoto, Hiroaki
    Toyokawa, Hideyoshi
    Sakai, Daisuke
    Wada, Hiroshi
    Satoi, Sohei
    Yamamoto, Tomohisa
    Nagano, Hiroaki
    Toyoda, Masanori
    Ajiki, Tetsuo
    Satake, Hironaga
    Tsuji, Akihito
    Miyamoto, Atsushi
    Tsujie, Masanori
    Takemura, Shigekazu
    Yanagihara, Kazuhiro
    Ioka, Tatsuya
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (03) : 461 - 468
  • [4] A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1202)
    Hiroaki Yanagimoto
    Hideyoshi Toyokawa
    Daisuke Sakai
    Hiroshi Wada
    Sohei Satoi
    Tomohisa Yamamoto
    Hiroaki Nagano
    Masanori Toyoda
    Tetsuo Ajiki
    Hironaga Satake
    Akihito Tsuji
    Atsushi Miyamoto
    Masanori Tsujie
    Shigekazu Takemura
    Kazuhiro Yanagihara
    Tatsuya Ioka
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 461 - 468
  • [5] Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study
    Shogo Kobayashi
    Hiroaki Nagano
    Daisuke Sakai
    Hidetoshi Eguchi
    Etsuro Hatano
    Masashi Kanai
    Satoru Seo
    Kojiro Taura
    Yutaka Fujiwara
    Tetsuo Ajiki
    Shigekazu Takemura
    Shoji Kubo
    Hiroaki Yanagimoto
    Hideyoshi Toyokawa
    Akihito Tsuji
    Hiroaki Terajima
    Satoshi Morita
    Tatsuya Ioka
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 699 - 709
  • [6] Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study
    Kobayashi, Shogo
    Nagano, Hiroaki
    Sakai, Daisuke
    Eguchi, Hidetoshi
    Hatano, Etsuro
    Kanai, Masashi
    Seo, Satoru
    Taura, Kojiro
    Fujiwara, Yutaka
    Ajiki, Tetsuo
    Takemura, Shigekazu
    Kubo, Shoji
    Yanagimoto, Hiroaki
    Toyokawa, Hideyoshi
    Tsuji, Akihito
    Terajima, Hiroaki
    Morita, Satoshi
    Ioka, Tatsuya
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (04) : 699 - 709
  • [7] Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: A Japan Clinical Oncology Group trial (JCOG 0805)
    Morizane, Chigusa
    Okusaka, Takuji
    Mizusawa, Junki
    Takashima, Atsuo
    Ueno, Makoto
    Ikeda, Masafumi
    Hamamoto, Yasuo
    Ishii, Hiroshi
    Boku, Narikazu
    Furuse, Junji
    CANCER SCIENCE, 2013, 104 (09): : 1211 - 1216
  • [8] Efficacy and Feasibility of Adjuvant Gemcitabine Plus Cisplatin Chemotherapy After Major Hepatectomy for Biliary Tract Cancer
    Mori, Shozo
    Aoki, Taku
    Shiraki, Takayuki
    Shimizu, Takayuki
    Yamaguchi, Takamune
    Park, Kyung-Hwa
    Matsumoto, Takatsugu
    Sakuraoka, Yuhki
    Iso, Yukihiro
    Kubota, Keiichi
    ANTICANCER RESEARCH, 2021, 41 (10) : 5231 - 5240
  • [9] A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancer
    Takashi Sasaki
    Hiroyuki Isayama
    Yousuke Nakai
    Yukiko Ito
    Ichiro Yasuda
    Nobuo Toda
    Hirofumi Kogure
    Keiji Hanada
    Hiroyuki Maguchi
    Naoki Sasahira
    Hideki Kamada
    Tsuyoshi Mukai
    Yoshihiro Okabe
    Osamu Hasebe
    Iruru Maetani
    Kazuhiko Koike
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 973 - 979
  • [10] Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401-MITSUBA)
    Ioka, Tatsuya
    Kanai, Masashi
    Kobayashi, Shogo
    Sakai, Daisuke
    Eguchi, Hidetoshi
    Baba, Hideo
    Seo, Satoru
    Taketomi, Akinobu
    Takayama, Tadatoshi
    Yamaue, Hiroki
    Takahashi, Masahiro
    Sho, Masayuki
    Kamei, Keiko
    Fujimoto, Jiro
    Toyoda, Masanori
    Shimizu, Junzo
    Goto, Takuma
    Shindo, Yoshitaro
    Yoshimura, Kenichi
    Hatano, Etsuro
    Nagano, Hiroaki
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2023, 30 (01) : 102 - 110
12345